全球体外肺模型市场：按类型、按应用、按最终用户、按地区

全球体外肺模型市场规模预计将从 2023 年的 2.45 亿美元增至 2030 年的 6.205 亿美元，预测期内复合年增长率为 14.2%。

图 1. 体外肺模型全球市场占有率(%)（按地区），2023 年

体外肺模型是一种旨在模拟人类肺生理和解剖特征的实验系统。它广泛应用于药物研发、毒性测试和肺部疾病研究。透过利用体外生长的人类肺细胞和组织，这些模型为动物实验提供了相对便宜且有效的替代方案。与动物模型相比，它还为研究人类肺部生物学和疾病病理提供了更现实和可控的环境。组织工程、微流体和其他技术的未来进展预计将有助于开发高度复杂的 3D 肺部模型，更好地再现体内肺部微环境。

市场动态：

全球体外肺模型市场的推动因素包括製药公司增加药物研发投资、严格的动物试验法规以及呼吸系统疾病盛行率的上升等。然而，与先进 3D 肺模型开发相关的高成本和短组织储存期预计将抑制市场成长。同时，微加工和 3D 生物列印技术的进步预计将为开发下一代仿生模型创造重要机会。人们日益关注开发包含来自个别患者的细胞和组织的个人化肺部模型，预计也将推动该市场的成长。

另一方面，市场开拓公司不断增加的研发预计将在预测期内进一步推动市场成长。例如，2023年3月6日，生物技术公司AlveoliX AG在Frontiers Media SA上发表了一项研究，旨在治疗气喘、慢性阻塞性肺病（COPD）和纤维化等多种呼吸系统疾病，但由于药物数量有限由美国食品药物管理局( FDA) 发表了一项题为「多重吸入平台，可在呼吸晶片中模拟气溶胶输送的原位模型」的研究。由于美国食品药物管理局(FDA)核准治疗这些严重肺部疾病的吸入药物数量有限，因此需要进行体内研究，以便在临床前研究中更准确地预测吸入颗粒的毒性。替代体外人类相关模型。

本研究的主要特点

• 该研究报告对全球体外肺模型市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
• 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
• 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球体外肺模型市场的主要企业。
• 该报告的见解使行销人员和公司负责人能够就未来的经营团队发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球体外肺模型市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
• 透过用于分析全球体外肺模型市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管场景
• 服务交付组合
• PEST分析
• 波特的分析
• 併购场景

第四章全球体外肺模型市场 -冠状病毒(COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章全球体外肺模型市场，依类型，2018-2030

• 2D模型
• 3D模型

第六章全球体外肺模型市场（按应用），2018-2030

• 药物研发和毒理学研究
• 生理学调查
• 3D模型开发
• 其他的

第七章 全球体外肺模型市场，依最终使用者划分，2018-2030 年

• 学术研究所
• 生物製药公司
• 其他的

第八章2018-2030年全球体外肺模型市场（按地区）

• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第9章 竞争形势

• Epithelix
• MATTEK
• Lonza
• Emulate
• AlveoliX AG
• Nortis
• CN Bio Innovations Ltd
• MIMETAS
• InSphero
• ATTC Global
• Tissuse GmbH
• Cn Bio Innovations Limited

第10章

• 调查方法
• 关于出版商

The global in vitro lung model market size is expected to reach US$ 620.5 Mn by 2030, from US$ 245.0 Mn in 2023, exhibiting a CAGR of 14.2% during the forecast period.

Figure 1. Global In Vitro Lung Model Market Share (%), By Region, 2023

In vitro lung models are experimental systems that aim to mimic the physiological and anatomical properties of the human lungs. They are widely used in drug discovery, toxicity testing, and studying lung diseases. By utilizing human lung cells and tissues grown outside of the body, these models offer a relatively affordable and effective alternative to animal testing. They also provide a more realistic and controllable environment to study human lung biology and disease pathology compared to animal models. Going forward, advances in tissue engineering, microfluidics, and other technologies are expected to help develop highly complex 3D lung models that can better recreate the in vivo lung microenvironment.

Market Dynamics:

The global in vitro lung model market is driven by factors such as rising drug R&D investments by pharmaceutical companies, stringent regulations regarding animal testing, and increasing prevalence of respiratory diseases. However, high costs associated with developing advanced 3D lung models and shorter shelf life of tissues are expected to restrain the market growth. Meanwhile, ongoing advances in microfabrication and 3D bioprinting technologies are projected to create significant opportunities for manufacturers to develop next-gen biomimetic models. The market is also anticipated to gain from growing focus on developing personalized lung models incorporating individual patient-derived cells and tissues.

On the other hand, rising research and development by market players is further expected to propel the market growth over the forecast period. For instance, on March 6, 2023, AlveoliX AG, a biotechnology company, published a study in Frontiers Media S.A., a peer-reviewed, open access, scientific journals, entitled "A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip" for various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and fibrosis, due to limited number of U.S. Food and Drug Administration, approved inhaled drugs for these serious lung conditions has led to a shift from in vivo towards the use of alternative in vitro human-relevant models to better predict the toxicity of inhaled particles in preclinical research.

Key features of the study:

• This report provides an in-depth analysis of the global In vitro lung model market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global In vitro lung model market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Histogen Inc., OliX Pharmaceuticals, Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy's Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global In vitro lung model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global In vitro lung model market

Detailed Segmentation:

• Global In Vitro Lung Model Market, By Type
  • 2D Model
  • 3D Model
• Global In Vitro Lung Model Market, By Application
  • Drug Discovery & Toxicology Studies
  • Physiological Research
  • 3D Model Development
  • Others
• Global In Vitro Lung Model Market, By End User
  • Academic and Research Institutes
  • Biopharmaceutical Companies
  • Others
• Global In Vitro Lung Model Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Global In Vitro Lung Model Market, Key Players
  • Epithelix
  • MATTEK
  • Lonza
  • Emulate
  • AlveoliX AG
  • Nortis
  • CN Bio Innovations Ltd
  • MIMETAS
  • InSphero
  • ATTC Global
  • Tissuse GmbH
  • Cn Bio Innovations Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global In Vitro Lung Model Market, By Type
  • Global In Vitro Lung Model Market, By Application
  • Global In Vitro Lung Model Market, By End User
  • Global In Vitro Lung Model Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising prevalence of lung diseases
  • High costs associated with animal models
  • Growing preference for 3D lung models over 2D models
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Service offering Portfolio
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global In Vitro Lung Model Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global In Vitro Lung Model Market, By Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• 2D Model
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• 3D Model
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global In Vitro Lung Model Market, By Application, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Drug Discovery & Toxicology Studies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Physiological Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• 3D Model Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global In Vitro Lung Model Market, By End User, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global In Vitro Lung Model Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Epithelix
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• MATTEK
• Lonza
• Emulate
• AlveoliX AG
• Nortis
• CN Bio Innovations Ltd
• MIMETAS
• InSphero
• ATTC Global
• Tissuse GmbH
• Cn Bio Innovations Limited
• Analyst Views

10. Section

• Research Methodology
• About us